{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:28:28Z","timestamp":1790137708682,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1007\/s11926-004-0061-9","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T10:06:52Z","timestamp":1180778812000},"page":"156-163","source":"Crossref","is-referenced-by-count":50,"title":["Antibodies in scleroderma: Direct pathogenicity and phenotypic associations"],"prefix":"10.1007","volume":"6","author":[{"given":"Lorinda","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00002281-200211000-00013","volume":"14","author":"JE Pope","year":"2002","unstructured":"Pope JE: Scleroderma overlap syndromes. Curr Opin Rheumatol 2002, 14:704\u2013710.","journal-title":"Curr Opin Rheumatol"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.4049\/jimmunol.167.12.7126","volume":"167","author":"X Zhou","year":"2001","unstructured":"Zhou X, Tan FK, Xiong M, et al.: Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol 2001, 167:7126\u20137133.","journal-title":"J Immunol"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00002281-200311000-00016","volume":"15","author":"ML Harris","year":"2003","unstructured":"Harris ML, Rosen A: Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies. Curr Opin Rheumatol 2003, 15:778\u2013784. This review highlights novel autoantibodies and novel phenotypic associations, as well as the potential role of autoantibodies in scleroderma.","journal-title":"Curr Opin Rheumatol"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","volume":"165","author":"S Sato","year":"2000","unstructured":"Sato S, Hasegawa M, Fujimoto M, et al.: Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000, 165:6635\u20136643.","journal-title":"J Immunol"},{"key":"61_CR5","first-page":"357","volume-title":"Primer on the Rheumatic Diseases","author":"FM Wigley","year":"2001","unstructured":"Wigley FM: Systemic sclerosis: clinical features. In Primer on the Rheumatic Diseases. Edited by Klippel JH. Atlanta: Arthritis Foundation; 2001:357\u2013364."},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.11179","volume":"48","author":"M Worda","year":"2003","unstructured":"Worda M, Sgonc R, Dietrich H, et al.: In vivo analysis of the apoptosis-inducing effect of anti-endothelial cell antibodies in systemic sclerosis by the chorionallantoic membrane assay. Arthritis Rheum 2003, 48:2605\u20132614.","journal-title":"Arthritis Rheum"},{"key":"61_CR7","first-page":"462","volume":"25","author":"VS Negi","year":"1998","unstructured":"Negi VS, Tripathy NK, Misra R, et al.: Anti-endothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension. J Rheumatol 1998, 25:462\u2013466.","journal-title":"J Rheumatol"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","volume":"46","author":"C Chizzolini","year":"2002","unstructured":"Chizzolini C, Raschi E, Rezzonico R, et al.: Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002, 46:1602\u20131613.","journal-title":"Arthritis Rheum"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1523-1747.2003.12097.x","volume":"120","author":"S Sato","year":"2003","unstructured":"Sato S, Hayakawa I, Hasegawa M, et al.: Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis. J Invest Dermatol 2003, 120:542\u2013547.","journal-title":"J Invest Dermatol"},{"key":"61_CR10","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","volume":"109","author":"E Saito","year":"2002","unstructured":"Saito E, Fujimoto M, Hasegawa M, et al.: CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 2002, 109:1453\u20131462.","journal-title":"J Clin Invest"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/1529-0131(200011)43:11<2464::AID-ANR13>3.0.CO;2-F","volume":"43","author":"FK Tan","year":"2000","unstructured":"Tan FK, Arnett FC, Reveille JD, et al.: Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles. Arthritis Rheum 2000, 43:2464\u20132471.","journal-title":"Arthritis Rheum"},{"key":"61_CR12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/1529-0131(200108)44:8<1855::AID-ART324>3.0.CO;2-Q","volume":"44","author":"DD Wallis","year":"2001","unstructured":"Wallis DD, Tan FK, Kielty CM, et al.: Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma). Arthritis Rheum 2001, 44:1855\u20131864.","journal-title":"Arthritis Rheum"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/art.10977","volume":"48","author":"PQ Hu","year":"2003","unstructured":"Hu PQ, Fertig N, Medsger TA, et al.: Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 2003, 48:1363\u20131373. These researchers used a highly sensitive enzyme-linked immunosorbent assay to study anti-topo-I titers in 59 patients with diffuse scleroderma. They showed that titers of anti-topo-I IgG and IgA correlated with the total skin score and disease activity in patients with scleroderma.","journal-title":"Arthritis Rheum"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/rheumatology\/keg170","volume":"42","author":"R Hesselstrand","year":"2003","unstructured":"Hesselstrand R, Scheja A, Shen GQ, et al.: The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology 2003, 42:534\u2013540.","journal-title":"Rheumatology"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","volume":"49","author":"JD Reveille","year":"2003","unstructured":"Reveille JD, Solomon DH: Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. Arthritis Rheum 2003, 49:399\u2013412. This review summarizes the sensitivity and specificity of various assays for autoantibodies associated with scleroderma. The authors provide guidelines for the use of autoantibody testing in clinical practice.","journal-title":"Arthritis Rheum"},{"key":"61_CR16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.10407","volume":"46","author":"L Schachna","year":"2002","unstructured":"Schachna L, Wigley FM, Morris S, et al.: Recognition of granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss. Arthritis Rheum 2002, 46:1873\u20131884. This paper emphasizes the importance of modification of autoantigens in the immune response of patients with scleroderma. The authors showed that ACAs target modified centromere proteins in a subset of limited scleroderma patients with ischemic digital loss.","journal-title":"Arthritis Rheum"},{"key":"61_CR17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2249.2002.01991.x","volume":"130","author":"H Eenennaam van","year":"2002","unstructured":"van Eenennaam H, Vogelzangs JHP, Bisschops L, et al.: Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations. Clin Exp Immunol 2002, 130:532\u2013540.","journal-title":"Clin Exp Immunol"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/art.10914","volume":"49","author":"DB Ulanet","year":"2003","unstructured":"Ulanet DB, Wigley FM, Gelber AC, et al.: Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension. Arthritis Rheum 2003, 49:85\u201392.","journal-title":"Arthritis Rheum"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/ar147","volume":"3","author":"R Brouwer","year":"2001","unstructured":"Brouwer R, Pruijn GJM, van Venrooij WJ: The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma. Arthritis Research 2001, 3:102\u2013106.","journal-title":"Arthritis Research"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","volume":"4","author":"R Brouwer","year":"2002","unstructured":"Brouwer R, Vree Egberts WTM, Hengstman GJD, et al.: Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome. Arthritis Res 2002, 4:134\u2013138.","journal-title":"Arthritis Res"},{"key":"61_CR21","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1002\/art.10673","volume":"46","author":"H Eenennaam van","year":"2002","unstructured":"van Eenennaam H, Vogelzangs JHP, Lugtenberg D, et al.: Identity of the RNase MRP- and RNase P-associated Th\/To autoantigen. Arthritis Rheum 2002, 46:3266\u20133272.","journal-title":"Arthritis Rheum"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.10760","volume":"48","author":"GM Mitri","year":"2003","unstructured":"Mitri GM, Lucas M, Fertig N et al.: A comparison between anti- Th\/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003, 48:203\u2013209. These authors compared patients with limited scleroderma who were ACA-positive to those who were anti-Th\/To antibody-positive. Patients with anti-Th\/To antibodies were found to have certain features more frequently associated with diffuse scleroderma, including pulmonary fibrosis and renal crisis.","journal-title":"Arthritis Rheum"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/art.1780331210","volume":"33","author":"Y Okano","year":"1990","unstructured":"Okano Y, Medsger TA: Antibody to Th ribonucleoprotein (nucleolar 7\u20132 RNA protein particle) in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1990, 33:1822\u20131828.","journal-title":"Arthritis Rheum"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.61.9.842","volume":"61","author":"M Kuwana","year":"2002","unstructured":"Kuwana M, Kimura K, Hirakata M, et al.: Differences in autoantibody response to Th\/To between systemic sclerosis and other autoimmune diseases. Ann Rheum Dis 2002, 61:842\u2013846.","journal-title":"Ann Rheum Dis"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.10729","volume":"48","author":"JM Yang","year":"2003","unstructured":"Yang JM, Hildebrandt B, Luderschmidt C, et al.: Human scleroderma sera contain autoantibodies to protein components specific to the U3 small nucleolar RNP complex. Arthritis Rheum 2003, 48:210\u2013217.","journal-title":"Arthritis Rheum"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.1780390712","volume":"39","author":"FC Arnett","year":"1996","unstructured":"Arnett FC, Reveille JD, Goldstein R, et al.: Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996, 39:1151\u20131166.","journal-title":"Arthritis Rheum"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","volume":"48","author":"V Steen","year":"2003","unstructured":"Steen V, Medsger TA: Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48:516\u2013522.","journal-title":"Arthritis Rheum"},{"key":"61_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L","volume":"42","author":"MA Burdt","year":"1999","unstructured":"Burdt MA, Hoffman RW, Deutscher SL, et al.: Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999, 42:899\u2013909.","journal-title":"Arthritis Rheum"},{"key":"61_CR29","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/1529-0131(200004)43:4<881::AID-ANR20>3.0.CO;2-G","volume":"43","author":"EL Greidinger","year":"2000","unstructured":"Greidinger EL, Casciola-Rosen L, Morris SM, et al.: Autoantibody recognition of distinctly modified forms of the U1-70- kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 2000, 43:881\u2013888.","journal-title":"Arthritis Rheum"},{"key":"61_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1523-1747.2003.12028.x","volume":"120","author":"Y Asano","year":"2003","unstructured":"Asano Y, Ihn H, Yamane K, et al.: The prevalence and clinical significance of anti-U1 RNA antibodies in patients with systemic sclerosis. J Invest Dermatol 2003, 120:204\u2013210.","journal-title":"J Invest Dermatol"},{"key":"61_CR31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2249.1999.00964.x","volume":"117","author":"GR Harvey","year":"1999","unstructured":"Harvey GR, Butts S, Rands AL, et al.: Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis. Clin Exp Immunol 1999, 117:395\u2013402.","journal-title":"Clin Exp Immunol"},{"key":"61_CR32","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/art.10521","volume":"46","author":"M Kuwana","year":"2002","unstructured":"Kuwana M, Kimura K, Kawakami Y: Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera. Arthritis Rheum 2002, 46:2742\u20132747.","journal-title":"Arthritis Rheum"},{"key":"61_CR33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/ard.61.2.183-a","volume":"61","author":"L Schoenroth","year":"2002","unstructured":"Schoenroth L, Fritzler M, Lonzetti L, et al.: Antibodies to [beta]2 glycoprotein I and cardiolipin in SSc. Ann Rheum Dis 2002, 61:183\u2013184.","journal-title":"Ann Rheum Dis"},{"key":"61_CR34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-774.x","volume":"105","author":"H Ihn","year":"1996","unstructured":"Ihn H, Sato S, Fujimoto M, et al.: Measurement of anticardiolipin antibodies by ELISA using beta 2-glycoprotein I (beta 2-GPI) in systemic sclerosis. Clin Exp Immunol 1996, 105:475\u2013479.","journal-title":"Clin Exp Immunol"},{"key":"61_CR35","first-page":"1450","volume":"27","author":"JE Pope","year":"2000","unstructured":"Pope JE, Thompson A: The frequency and significance of anticardiolipin antibodies in scleroderma. J Rheumatol 2000, 27:1450\u20131452.","journal-title":"J Rheumatol"},{"key":"61_CR36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.62.6.589","volume":"62","author":"CM Antonioli","year":"2003","unstructured":"Antonioli CM, Danieli E, Airo P, et al.: More on anticardiolipin and anti-beta 2 glycoprotein I in systemic sclerosis. Ann Rheum Dis 2003, 62:589\u2013590.","journal-title":"Ann Rheum Dis"},{"key":"61_CR37","first-page":"864","volume":"21","author":"H Endo","year":"1994","unstructured":"Endo H, Hosono T, Kondo H: Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994, 21:864\u2013870.","journal-title":"J Rheumatol"},{"key":"61_CR38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/1529-0131(200112)45:6<533::AID-ART379>3.0.CO;2-D","volume":"45","author":"AL Wutzl","year":"2001","unstructured":"Wutzl AL, Foley RN, O\u2019Driscoll BR, et al.: Microscopic polyangiitis presenting as pulmonary-renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase. Arthritis Care Res 2001, 45:533\u2013536.","journal-title":"Arthritis Care Res"},{"key":"61_CR39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2177\/jsci.25.473","volume":"25","author":"N Miyata","year":"2002","unstructured":"Miyata N, Kobayashi T, Matsukawa Y, et al.: Anti-neutrophil cytoplasmic autoantibody-associated rapid progressive glomerulonephritis complicated with both limited and diffuse scleroderma. Nihon Rinsho Meneki Gakkai Kaishi 2002, 25:473\u2013479.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"61_CR40","first-page":"2666","volume":"29","author":"S Casari","year":"2002","unstructured":"Casari S, Haeney M, Farrand S, et al.: Antineutrophil cytoplasmic antibodies: a \"red flag\" in patients with systemic sclerosis. J Rheumatol 2002, 29:2666\u20132667.","journal-title":"J Rheumatol"},{"key":"61_CR41","first-page":"1248","volume":"30","author":"D Khanna","year":"2003","unstructured":"Khanna D, Aggarwal A, Bhakuni DS, et al.: Bactericidal\/permeability- increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 2003, 30:1248\u20131252.","journal-title":"J Rheumatol"},{"key":"61_CR42","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.1780310310","volume":"31","author":"DR Fregeau","year":"1988","unstructured":"Fregeau DR, Leung PSC, Coppel RL, et al.: Autoantibodies to mitochondria in systemic sclerosis: frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum 1988, 31:386\u2013392.","journal-title":"Arthritis Rheum"},{"key":"61_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1386-6346(01)00138-3","volume":"22","author":"J Tojo","year":"2002","unstructured":"Tojo J, Ohira H, Suzuki T, et al.: Clinicolaboratory characteristics of patients with primary biliary cirrhosis associated with CREST symptoms. Hepatol Res 2002, 22:187\u2013195.","journal-title":"Hepatol Res"},{"key":"61_CR44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/jaut.1994.1030","volume":"7","author":"J Whyte","year":"1994","unstructured":"Whyte J, Hough D, Maddison PJ, et al.: The association of primary biliary cirrhosis and systemic sclerosis is not accounted for by cross reactivity between mitochondrial and centromere antigens. J Autoimmun 1994, 7:413\u2013424.","journal-title":"J Autoimmun"},{"key":"61_CR45","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.10965","volume":"48","author":"Y Katsumata","year":"2003","unstructured":"Katsumata Y, Suzuki T, Kuwana M, et al.: Anti-c-Mpl (thrombopoietin receptor) autoantibody-induced amegakaryocytic thrombocytopenia in a patient with systemic sclerosis. Arthritis Rheum 2003, 48:1647\u20131651.","journal-title":"Arthritis Rheum"},{"key":"61_CR46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2002.01756.x","volume":"127","author":"KJ Griffith","year":"2002","unstructured":"Griffith KJ, Ryan JP, Senecal J-L, et al.: The cytoplasmic linker protein CLIP-170 is a human autoantigen. Clin Exp Immunol 2002, 127:533\u2013538.","journal-title":"Clin Exp Immunol"},{"key":"61_CR47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","volume":"349","author":"T Berger","year":"2003","unstructured":"Berger T, Rubner P, Schautzer F, et al.: Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med 2003, 349:139\u2013145.","journal-title":"N Engl J Med"},{"key":"61_CR48","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, et al.: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526\u20131533. This study demonstrates the predictable appearance of autoantibodies before the diagnosis of SLE, emphasizing the probable pathogenic role of certain autoantibodies in autoimmune diseases.","journal-title":"N Engl J Med"},{"key":"61_CR49","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BAW, Berglin E, et al.: Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741\u20132749.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-004-0061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-004-0061-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-004-0061-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:47:14Z","timestamp":1559422034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-004-0061-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s11926-004-0061-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}